Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma.
about
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study.Surface molecule CD229 as a novel target for the diagnosis and treatment of multiple myeloma.Long-term results of thalidomide and dexamethasone (thal-dex) as therapy of first relapse in multiple myeloma
P2860
Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
Thalidomide maintenance follow ...... stem cell support in myeloma.
@ast
Thalidomide maintenance follow ...... stem cell support in myeloma.
@en
Thalidomide maintenance follow ...... stem cell support in myeloma.
@nl
type
label
Thalidomide maintenance follow ...... stem cell support in myeloma.
@ast
Thalidomide maintenance follow ...... stem cell support in myeloma.
@en
Thalidomide maintenance follow ...... stem cell support in myeloma.
@nl
prefLabel
Thalidomide maintenance follow ...... stem cell support in myeloma.
@ast
Thalidomide maintenance follow ...... stem cell support in myeloma.
@en
Thalidomide maintenance follow ...... stem cell support in myeloma.
@nl
P2093
P2860
P356
P1476
Thalidomide maintenance follow ...... stem cell support in myeloma.
@en
P2093
Brad S Kahl
Julie E Chang
Mark B Juckett
Natalie S Callander
Teri L Mitchell
Walter L Longo
P2860
P304
P356
10.3816/CLM.2008.N.018
P577
2008-06-01T00:00:00Z